GGrantIndex
Sort

23,748 grants matching melanoma

Administration, Evaluation and Planning Core

$203,185
Thomas S. Kupper · Brigham And Women'S Hospital · P50 · FY2010 · CA

The Cutaneous Biology of MAGE Transcription Factors

$203,175
Jack B Longley · University Of Wisconsin-Madison · R21 · FY2012 · AR

NAC for melanoma chemoprevention

$203,175
Douglas Grossman · University Of Utah · R21 · FY2009 · AR

Fluorescence molecular tomography to study T cell infiltration into tumors

$203,153
Victor H. Engelhard · University Of Virginia · R21 · FY2014 · CA

VPF/VEGF IN NORMAL AND NEOPLASTIC SKIN ANGIOGENESIS

$203,134
Massachusetts General Hospital · R01 · FY2003 · CA

Abramson Cancer Center Support Grant

$203,125
Robert H Vonderheide · University Of Pennsylvania · P30 · FY2024 · CA

Abramson Cancer Center Support Grant

$203,125
Robert H Vonderheide · University Of Pennsylvania · P30 · FY2025 · CA

Cancer Pharmacokinetics and Pharmacodynamics Facility

$203,091
Jan Hendrik Beumer · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA

The role of CADM1 in malignant melanoma

$202,939
Edward Hartsough · Drexel University · R00 · FY2019 · CA

Oral Cancer Screening via Spectral Cytopathology

$202,928
Max Diem · Northeastern University · R21 · FY2010 · CA

Combined ATRA and ipilimumab treatment to reduce immunosuppression in melanoma patients

$202,928
Martin McCarter · University Of Colorado Denver · R21 · FY2015 · CA

Autophagy regulation of prostate tumor development

$202,928
Andrew M Thorburn · University Of Colorado Denver · R21 · FY2016 · CA

Novel injectable resiquimod formulation for treatment of metastatic cancers

$202,854
Yen T Wang · Curebiotech, Inc. · R43 · FY2017 · CA

Cancer Pharmacokinetics and Pharmacodynamics Facility

$202,835
Jan Hendrik Beumer · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA

Cancer Pharmacokinetics and Pharmacodynamics Facility

$202,835
Jan Hendrik Beumer · University Of Pittsburgh At Pittsburgh · P30 · FY2019 · CA

Exploiting Drug Addiction to Improve the Efficacy of MAPK Pathway Targeted Therapy in BRAF and NRAS Mutant Melanoma

$202,819
Roger S Lo · University Of California Los Angeles · R21 · FY2018 · CA

UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis

$202,809
Shiyong Wu · Ohio University Athens · R01 · FY2011 · CA

Targeting Gene Delivery to the CNS Blood-Brain Barrier

$202,781
Irvin S.y. Chen · University Of California Los Angeles · R21 · FY2008 · NS

Discovering and Characterizing Novel Pregnancy-Associated Cancers

$202,673
Casey Crump · Icahn School Of Medicine At Mount Sinai · R21 · FY2016 · CA

Clinical Trail of Vaccine in Combination with Toll-Like Receptor (TLR)

$202,647
Patrick Hwu · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA

CANCER AND LEUKEMIA GROUP B

$202,614
University Of Chicago · U10 · FY2002 · CA

IMMUNODERMATOLOGICAL THERAPY OF SKIN CANCER

$202,599
University Of Alabama At Birmingham · R01 · FY2000 · CA

Epidemiology of MGUS in Southeastern Minnesota

$202,590
S Vincent Rajkumar · Mayo Clinic Rochester · P01 · FY2008 · CA

Functional Attributes of a CD8+BTLA+ T cell subset in Adoptive T Cell Therapy

$202,536
Chantale Bernatchez · University Of Tx Md Anderson Can Ctr · R21 · FY2014 · CA

Development of New Imaging Tools for the Early Detection of Buruli Ulcer Disease

$202,500
George Zouridakis · University Of Houston · R21 · FY2010 · AR